Vitrectomy Devices Market Size, Share, Analysis, Trends, Growth, 2032

Vitrectomy Devices Industry Prospective:

The global vitrectomy devices market size was worth around USD 1,421.04 million in 2023 and is predicted to grow to around USD 2,656.81 million by 2032 with a compound annual growth rate (CAGR) of roughly 7.20% between 2024 and 2032.

Request Free Sample

Vitrectomy Devices Market: Overview

Vitrectomy devices are medical equipment or tools used during a vitrectomy procedure. It is a form of eye surgery that focuses on treating medical problems related to the eye’s vitreous and retina. The surgery is carried out by an ophthalmologist and may include different types of procedures. For instance, the surgery may aim at helping repair a retina that has dislocated or detached from the eye wall. In other cases, the procedure may be directed toward removing foreign substances or blood that may be otherwise blocking the light from properly focusing on the retina. Additionally, it may also be carried out for the removal of scar tissue that has been tearing or wrinkling the retina resulting in poor vision. During the procedure, the medical professional may have to remove either some or all vitreous from the middle area of the eye depending on the final condition. In such cases, the vitreous is replaced with a bubble that is made of oil gas or saline water. Vitrectomy is carried out in case of the presence of a macular hole, retinal detachment, diabetic retinopathy, eye injury, and problems that may arise during a cataract surgery. The devices used during vitrectomy processes include items such as vitreous cutters, vitrectomy machines, micro-scissors, infusion cannulas, endo laser probes, and others.

Key Insights:

• As per the analysis shared by our research analyst, the global vitrectomy devices market is estimated to grow annually at a CAGR of around 7.20% over the forecast period (2024-2032)
• In terms of revenue, the global vitrectomy devices market size was valued at around USD 1,421.04 million in 2023 and is projected to reach USD 2,656.81 million, by 2032.
• The vitrectomy devices market is projected to grow at a significant rate due to the growing cases of diabetic retinopathy
• Based on the application, the diabetic retinopathy segment is growing at a high rate and will continue to dominate the global market as per industry projection
• Based on the type, the vitrectomy machines segment is anticipated to command the largest market share
• Based on region, North America is projected to dominate the global market during the forecast period

Request Free Sample

Vitrectomy Devices Market: Growth Drivers

Growing cases of diabetic retinopathy will drive the market demand rate

The global vitrectomy devices market is expected to grow due to the growing number of diabetic retinopathy across the globe. The medical condition is induced by diabetes, one of the most prevalent diseases worldwide. As per the World Health Organization (WHO), more than 422 million people worldwide are affected by diabetes. Along with other associated complications, diabetic retinopathy is a common disease that affects patients with diabetic conditions. It is caused by the damage of blood vessels present in the tissue at the back of the eye also known as the retina. The most common risk factor is poorly managed diabetes. At the beginning of the condition, patients show mild symptoms such as blurred vision. However, if left untreated or improperly managed, it can lead to complete blindness. It affects patients with type 1 and type 2 diabetes. As the disease progresses, patients report additional symptoms such as vision loss, fluctuating vision, or spots floating in the patient’s vision. There are two main types of diabetic retinopathy. They are advanced or proliferative and early or non-proliferative diabetic retinopathy (NPDR). Complications that arise due to the condition include retinal detachment, vitreous hemorrhage, glaucoma, and blindness. As per the National Institutes of Health (NIH), the condition affects around 285 million people with diabetic mellitus.

Surging investments in device technology development may generate a massive growth rate

The accelerating pressure on the global healthcare infrastructure has caused medical device manufacturers to invest more in improved tools and devices that ensure superior precision and higher performance. Furthermore, these tools are designed to be more patient-friendly to deliver exceptional medical care. For instance, the vitrectomy platforms provided by companies such as DORC, Bausch+Lomb, and Alcon are designed to improve surgery efficiency and safer removal of vitreous while also diminishing vitreoretinal traction. They are equipped with dual-cutter technology. Furthermore, experts in vitrectomy are predicting the introduction of robotic solutions in surgery rooms will alter the global vitrectomy devices market growth rate during the forecast period.

Vitrectomy Devices Market: Restraints

Surgical complications associated with vitrectomy will limit the market’s expansion rate

The global industry for vitrectomy devices is expected to be restricted due to the complications associated with the surgical procedure. Some of the most common risks involved during vitrectomy include excess bleeding, infection, surgery-induced new retinal detachment, high eye pressure, lens damage, change in refractive error, post-surgical problems with eye movement, and elevated rate of cataract formation. Certain cases have been reported suggesting that the surgery may not be successful in the first attempt but may need another procedure.

Vitrectomy Devices Market: Opportunities

Growing construction of new eye clinics will aid in higher revenue generation during the projection period

The global vitrectomy devices industry is projected to come across several new growth avenues in the future. The growth trend is expected to be directly impacted by the rising development and construction of new eye clinics equipped with state-of-the-art facilities. In December 2022, UC Davis Health Institute in the US inaugurated its new facility called the Ernest E. Tschannen Eye Institute Building. Through the new facility, the company aims to deliver excellent eye care to patients from across the globe. Furthermore, the building is also equipped with a research unit for conducting regulatory studies and analysis. In October 2021, Mount Sinai Health System announced the launch of the first eye stroke service in New York City USA for diagnosing and treating patients with eye stroke. In February 2024, Optegra, a leading eye healthcare group, unveiled its Cataract and Refractive Surgery Fellowship Program thus contributing to the global eye health industry. Furthermore, the rising rate of accommodating eye surgeries in healthcare reimbursement plans and growing patient awareness may also contribute to the industry’s growth rate.

Expansion into new markets may prove beneficial for the market players

The manufacturers of vitrectomy devices must explore new markets for higher return on investment during the projection period. The growing healthcare burden across the globe as well as the rising demand for quality primary medical care have created an extensive buyer base for modern medicinal devices and tools. Emerging economies with higher population density and a steady rise in healthcare-related investments can deliver excellent expansion opportunities for the global vitrectomy devices market as these regions are on the continuous lookout for affordable yet effective medical tools.

Vitrectomy Devices Market: Challenges

Circulation of uncertified medical devices in the market could pose expansion threats

The global industry for vitrectomy devices is expected to be challenged by the growing concerns over escalating incidents of uncertified or unregulated devices in the market. These tools are made of low-quality materials and do not offer the same precision as regulated counterparts thus posing risk to the patients. Moreover, the lack of infrastructure required for conducting vitrectomy surgeries in underdeveloped countries may add to the existing growth-inhibiting concerns.

Vitrectomy Devices Market: Segmentation

The global vitrectomy devices market is segmented based on application, type, and region.

Based on the application, the global market segments are vitreous hemorrhage, diabetic retinopathy, macular hole, retinal detachment, and others. In 2023, the highest growth was observed in the diabetic retinopathy segment. The exponential rise in the number of diabetic patients across the globe is a major propeller for higher segmental demand. Some of the early symptoms of the condition include dark vision arras, blurriness, and difficulty in color perception. According to NIH, the condition is expected to affect more than 191 million people by 2030.

Based on the type, the global market divisions are vitrectomy machines, photocoagulation lasers, vitrectomy packs, and illumination devices. In 2023, the highest demand was observed for vitrectomy machines as they are used in all medical procedures concerning vitrectomy. Furthermore, the growing advancements in machine technology will lead to improved patient care delivery during the projection period. The average cost of vitrectomy machines is over USD 50,000 depending on the model and the overall features.

Vitrectomy Devices Market: Report Scope

Vitrectomy Devices Market: Regional Analysis

North America will lead the market growth rate during the projection period

The global vitrectomy devices market will be led by North America during the forecast period. The US and Canada will emerge as the leading contributors to the regional market revenue. These countries have existing robust medical infrastructure driven by the presence of multiple specialist hospitals equipped with state-of-the-art diagnostic and surgery tools. Furthermore, the regional population has greater access to medical care facilitated by the availability of national healthcare schemes. As per official data, the US is one of the leading nations in terms of healthcare expenditure. In 2022, the region’s total healthcare cost was close to USD 4.51 trillion. In 2021, more than 85% of Canadian citizens had access to primary and advanced medical care. The growing development of eye-treatment-specific medical facilities in North America as well as the increased emphasis on developing affordable medical care will contribute to the region’s overall revenue. In October 2023, Canada witnessed the inauguration of the Windsor Surgical Centre which is expected to treat multiple eye surgery patients annually. The facility is built across 12,000 square feet and equipped with breakthrough technologies.

Vitrectomy Devices Market: Competitive Analysis

The global vitrectomy devices market is led by players like:

• Leica Microsystems (a division of Danaher Corporation)
• Dutch Ophthalmic Research Center (D.O.R.C.) International B.V.
• Carl Zeiss Meditec AG
• Beaver-Visitec International (BVI)
• NIDEK Co. Ltd.
• Insight Instruments Inc.
• IRIDEX Corporation
• Synergetics USA Inc.
• Peregrine Surgical
• Alcon (a division of Novartis)
• Geuder AG
• Topcon Corporation
• Bausch + Lomb (a division of Bausch Health Companies Inc.)
• Optos (a division of Nikon)
• Rumex International Co.

The global vitrectomy devices market is segmented as follows:

By Application

• Vitreous Hemorrhage
• Diabetic Retinopathy
• Macular Hole
• Retinal Detachment

By Type

• Vitrectomy Machines
• Photocoagulation Lasers
• Vitrectomy Packs
• Illumination Devices

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa